Eli Lilly and Company announced today that Phase III trial data showed the addition of Lilly’s GEMZAR® to the current standard of care provided a statistically significant increase in progression-free survival at three years for women with locally advanced cervical cancer.
Archive for May, 2009
Study Showed Lilly’s GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer … (PR Newswire via Yahoo!…
Published May 31st, 2009 in Osteosarcoma News. 0 CommentsFundraiser for Union boy with bone marrow condition (Northwest Herald)
Published May 31st, 2009 in Osteosarcoma News. 0 CommentsUNION – Jenny Christiansen felt humbled when family and friends recently decided to put together a summer fundraiser for her son.
PET Scan Can Non-Invasively Measure Early Assessment Of Treatment For Common Type Of Breast Cancer (Science Daily)
Published May 31st, 2009 in Osteosarcoma News. 0 CommentsNon-invasive imaging can measure how well patients with the most common form of breast cancer — estrogen receptor positive type — respond to standard aromatase inhibitor therapy after only two weeks and shows similar findings that more invasive needle sampling identifies, according to new research.
‘Her tumour weighed the same as two bags of sugar’: Melanie Slade on her sister’s battle with kidney cancer (Daily Mail)
Published May 30th, 2009 in Osteosarcoma News. 0 Comments‘Her tumour weighed the same as two bags of sugar’: Melanie Slade on her sister’s battle with kidney cancer
Cancer survivor’s pet receiving chemotherapy (Milwaukee Journal Sentinel)
Published May 30th, 2009 in Osteosarcoma News. 0 CommentsWhen Christine was battling leukemia, her dad promised to get her a dog when she recovered.
Recent Comments